Dr. van den Berg is responsible for the translational science activities for the Rockville R&D center of GSK Vaccines. In this role he leads multidisciplinary teams of clinicians, molecular biologists, immunologists, and data scientists with the objective to tackle key scientific questions for GSK discovery and development programs and vaccine technology platforms. For this, the team collaborates with various partners in the academic world, governmental organizations, and other private companies. Dr. van den Berg has served in this role since 2016. He joined GSK in 2010 as bioinformatician supporting translational research. Before this he worked as a postdoctoral researcher at the Katholieke Universiteit Leuven on data integration of heterogeneous biological data. He received a Ph.D. in Life Sciences from the Universiteit van Amsterdam on Multivariate data analysis of microbial fermentation processes.